|
|
We Have Recently Made Changes to Our Website, If you are unable to find something Specific, Please Search Below
Publish Date : 9/8/2004 4:08:00 PM Source : SkinCareIndia Health News Medical Research Council (MRC) researchers are part of an international consortium which has just received $14.5 million (12 million Euros) to create a European Network of Excellence in ‘Epigenetics’, called ‘The Epigenome’, announced on 6 September 2004.
Epigenetics is the term used to describe the field of science which is trying to interpret how all the information generated after finally mapping the human genome is actually used in real life. Having all the genetic information is only the first step – we now need to understand how cells make sense of the DNA codes they are given to make them a particular cell with a particular job for life, and what prompts them to keep functioning normally and generate replicas of themselves. Understanding exactly how particular types of cells translate their instructions from one universal DNA code, and how this information gets used by the cells to determine how a human body is made and functions is commonly known as the post genome challenge. This is the next piece of the jigsaw from knowing what the basic outline ‘instructions’ to build a human are, which we now know from the genome. Professor Amanda Fisher of the MRC Clinical Sciences Centre, Hammersmith, and Professor Wendy Bickmore at the MRC Human Genetics Unit, Edinburgh, are leading the Consortia’s Public Sciences Activities, which aim to disseminate knowledge and stimulate discussion on issues raised by advances in epigenetic research. Epigenome will involve the following ‘Public Science’ activities: -- Public Science web site -- Training courses for non-specialists in genetics/development, school visits, open days, contribution to local Science Festivals, radio and TV. This will specifically include a show on “cell fate”, developed primarily for the Edinburgh Science Festival (aimed at a teenage audience) by members from the MRC HGU, to then tour schools in Scotland, London and Heidelberg within the first 12 months of the grant. -- Europe-wide talks and discussion of science/medicine/ethics via the ‘Café Scientifique’. This initiative will be expanded by the PSO, to include venues for Vienna, Amsterdam and Munich/Heidelberg, within the first 12 months of the grant. Network members will be invited to make presentations at the previously established CS in London, Paris and Geneva within this period. -- A project linking Science and Art will begin at the Institute of Contemporary Art (ICA) in London. This will explore how genomic and epigenetic information shapes life, and could for example include the topics of ‘risk’ and ‘cultural attitudes to life and its origins’. This will be explored through debate, theater and alternative forms of media. Professor Fisher said: “The Network brings together scientists from many disciplines that are tackling this question at different levels to pool expertise, resources and knowledge in a real push to accelerate our understanding of the genetic blueprint. This will help us translate knowledge about the mechanics of the human body and its processes into new ways to understand health and disease.” “This exciting collaboration will help us understand how, despite having the same DNA, cells receive their different instructions to fulfil their own unique jobs and to continue to replenish and divide ensuring the imprinted memory of what they are meant to do gets passed from one generation of cells to another. This all relates to what genes are switched ‘on’ or ‘off’ at any given time. If there is a fault and a cell loses its ‘memory’ of what function it is supposed to do then it isn’t passed on to the new cells at replication, and there is a trigger for disease. “Knowing more about these processes is what helps scientists turn knowledge into new ideas about preventing and treating disease, so it’s a great challenge to be part of this team trying to piece together this crucial information.” Professor Neil Brockdorff based at the MRC Clinical Sciences Centre makes up the rest of the MRC team contributing to this European venture. Medical Research Council http://www.britainusa.com |
|
Cervical cancer vaccine breakthrough
Publish Date : 11/15/2004 1:16:00 PM Scientists say they have tested a vaccine, Cervarix, that protects women from two strains of HPV (human papillomavirus) which are responsible for 70% of cervical cancers. Beyond Tactical Struggles over Public Policy -The President's Council on Bioethics Publish Date : 11/15/2004 1:15:00 PM An on-stage discussion with William F May, PhD. Bioethicist and Author Human mad cow disease, there are many different forms of it Publish Date : 11/15/2004 1:15:00 PM Depending on your genetic makeup, vCJD (Varian Mad Cow Disease) will manifest itself differently, say researchers. This means vCJD may be present in some areas without being detected (vCJD means the human form of mad cow disease). New online tool kit on HIV/AIDS prevention for sex workers Publish Date : 11/15/2004 1:11:00 PM GTZ, WHO and sex work networks share information and lessons learned - The German technical cooperation (GTZ) and the World Health Organization (WHO), in collaboration with sex work networks around the world..... Anti-drug driving campaign wins award Publish Date : 11/10/2004 7:34:00 PM A road safety initiative to stop people driving under the influence of drugs has won an award at the THINK road safety conference. Text Messaging Helps Patients in Developing Countries Manage HIV/AIDS Treatment Publish Date : 11/10/2004 7:33:00 PM Wired News on Thursday examined how HIV/AIDS treatment counselors in countries where health care .... Roche Diagnostics Launches Highly-sensitive Polymerase Chain Reaction System Publish Date : 11/10/2004 7:32:00 PM Roche Diagnositcs has begun sales of it's real-time polymerase chain reaction (PCR) system LightCycler ST300, a highly-sensitive gene analysis system. 3 by 5 Initiative for HIV 'Probably Will Not' Meet Treatment Publish Date : 11/10/2004 7:31:00 PM The World Health Organization's 3 by 5 Initiative goal of treating three million HIV-positive people with antiretroviral ........ Manufacturing Approval for Statmark Influenza Virus Detection Reagent Publish Date : 11/10/2004 7:30:00 PM Nichirei (TSe: 2871), a leading Japanese food processing company, has announced that it has ..... US Health Improvements Slowing - Alarm at High Infant Mortality Rates and Obesity Publish Date : 11/10/2004 7:28:00 PM Although the overall health of US residents continues to improve, health indicators show that ... Total Results : 3044 More News (Opens in New Window) : [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 Next Page |
|